Management Committee

Christopher Rowe


Prof Rowe BMBS, FRACP, MD, FAANMS is a nuclear medicine physician and neurologist, with over 20 years of experience in dementia research and patient care. He is the Director of Molecular Imaging Research at Austin Health, Melbourne, Professorial Fellow University of Melbourne, a NHMRC Practitioner Fellow and is the inaugural Director of the Australian Dementia Network. His research focus is molecular imaging of neurodegenerative diseases, particularly AD, for better understanding, earlier more accurate detection, and to facilitate development of early therapeutic interventions. He has over 300 publications and is in the 2018 Highly Cited Researcher list of the top 1% world-wide for neuroscience and has received the 2011 US Society of Nuclear Medicine Kuhl-Lassen Award for Outstanding Contribution to Brain Imaging and the 2016 Christopher Clark Award for advancing human amyloid imaging.

Perminder Sachdev

Deputy Director

Prof Sachdev AM MBBS MD FRANZCP PhD FAHMS is Scientia Professor of Neuropsychiatry, Co-Director of the Centre for Healthy Brain Ageing (CHeBA) in the School of Psychiatry, UNSW Sydney, and Clinical Director of the Neuropsychiatric Institute (NPI) at the Prince of Wales Hospital, Sydney, Australia. His major areas of research are drug-induced movement disorders, brain imaging, cognitive ageing and dementia. He has published over 600 peer-reviewed journal papers and 6 books, including one for lay readers (The Yipping Tiger and other tales from the neuropsychiatric clinic) and a book of poems (A migrant’s musings). He was named NSW Scientist of the year for Biomedical Sciences in 2010. In 2011, he was appointed Member of the Order of Australia (AM) for services to medical research. In 2018, he won the DARF-Yulgilbar Innovation Award for dementia research.

Stephanie Ward

Clinical Quality Registry Lead

Dr Ward BMed FRACP MPH is a practising geriatrician based at the Prince of Wales Hospital, Sydney, experienced in the diagnosis and care of persons living with dementia and cognitive impairment in a variety of settings and was involved in establishing the pilot dementia clinical quality registry project at Monash University. She leads clinician engagement with the ADNet Registry.

Sharon Naismith

Memory Clinics Lead

Prof Naismith is a Clinical Neuropsychologist, NHMRC Dementia Leadership Fellow and Heads the Healthy Brain Ageing Program at the Brain and Mind Centre. Her work focuses on modifiable risk factors for dementia and clinical interventions for early cognitive decline including cognitive training, sleep and pharmacological interventions. She leads an NHMRC Centre of Research Excellence to ‘Optimise Sleep in Brain Ageing and Neurodegeneration (CogSleep).

Colin Masters

Screening and Trials Lead

Prof Masters' career over the last 35 years is widely acknowledged as having had a major influence on Alzheimer’s disease research worldwide, particularly the collaborative studies conducted with Konrad Beyreuther in which they discovered the proteolytic neuronal origin of the Aβ amyloid protein which causes Alzheimer’s disease. More recently, his focus has been on describing the natural history of Alzheimer’s disease as a necessary preparatory step for therapeutic disease modification. His achievements have been recognised by the receipt of many international awards.

Michael Breakspear

Technology Lead

Prof Breakspear MB BS, PhD, FRANZCP is a professor of neuroscience at the University of Newcastle and a consultant psychiatrist. He runs a research program of computational and translational neuroimaging. He is lead CI of the technological arm of ADNeT.

Peter Schofield

Business Lead

Prof Schofield AO FAHMS PhD DSc is CEO of NeuRA (Neuroscience Research Australia) and a Professor of Medicine at UNSW. His research interests focus on genetics of brain function, neurodegenerative and psychiatric disorders such as Alzheimer's disease and bipolar disorder. He is a site leader for the Dominantly Inherited Alzheimer Network. He served as the Interim Director of the NNIDR in 2016-17.

Cherry Ann Santos

Operations Manager

With more than 15 years' experience in program and project management roles in Australia and Asia, Cherry brings a strategic, proactive and people-oriented approach to ADNeT. Prior to joining ADNeT, Cherry led the development of key infrastructure projects for the Faculties of Science, Engineering, Medicine, and Architecture of the University of Melbourne. She also has extensive consulting experience with the Asian Development Bank on various regional cooperation projects across Asia. Cherry holds a Master of Development Economics and a Master of Management.

Deborah Remfry

Patient and Public Involvement Coordinator

Deborah has a degree in Commerce and Applied Psychology with post graduate qualifications in strategic planning for urban environments. Her professional life has required regular engagement with people, articulating the nature of the issues and challenges that face the community both now and in the future. Deborah, as the Patient and Pubic Involvement Coordinator is the primary carer for her husband John who has been diagnosed with Dementia with Lewy Bodies. Deborah also has personal experience of friends who have a diagnosis of Alzheimer’s, vascular dementia and younger onset dementia. Deborah is aware of the importance that a balanced view is key when interpreting the needs of a diverse group of people when facing a diagnosis of dementia.

Larry Ward

Business Manager

Dr Ward is a highly experienced biotechnology executive with over 20 years’ experience in the biotechnology industry at companies including AMRAD, Virax Holdings and Medicines Development for Global Health (MDGH) in positions spanning from Laboratory Director through to CEO. Dr. Ward heads the business development function within ADNeT as well as in the related organisations AIBL and CRC for Mental Health.